phloretin has been researched along with Carcinoma, Non-Small Cell Lung in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kunimasa, K | 1 |
Nagano, T | 1 |
Shimono, Y | 1 |
Dokuni, R | 1 |
Kiriu, T | 1 |
Tokunaga, S | 1 |
Tamura, D | 1 |
Yamamoto, M | 1 |
Tachihara, M | 1 |
Kobayashi, K | 1 |
Satouchi, M | 1 |
Nishimura, Y | 1 |
Min, J | 1 |
Huang, K | 1 |
Tang, H | 1 |
Ding, X | 1 |
Qi, C | 1 |
Qin, X | 1 |
Xu, Z | 1 |
Ma, L | 1 |
Wang, R | 1 |
Nan, Y | 1 |
Li, W | 1 |
Wang, Q | 1 |
Jin, F | 1 |
3 other studies available for phloretin and Carcinoma, Non-Small Cell Lung
Article | Year |
---|---|
Glucose metabolism-targeted therapy and withaferin A are effective for epidermal growth factor receptor tyrosine kinase inhibitor-induced drug-tolerant persisters.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Blotting, Western; Carcinoma, Non-Small-Cell Lung; | 2017 |
Phloretin induces apoptosis of non-small cell lung carcinoma A549 cells via JNK1/2 and p38 MAPK pathways.
Topics: Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cell Proliferat | 2015 |
Phloretin exhibits an anticancer effect and enhances the anticancer ability of cisplatin on non-small cell lung cancer cell lines by regulating expression of apoptotic pathways and matrix metalloproteinases.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Caspase 3; Caspase 9; Cell Line, T | 2016 |